Home > Newsletters > The QMN Weekly Bulletin > Qualitest Recalls Pain Drug Tablets on Oversize Concerns
The QMN Weekly Bulletin
Oct. 26, 2012 | Vol. 4 No. 43
Qualitest Recalls Pain Drug Tablets on Oversize Concerns
Qualitest, a subsidiary of Endo Health Solutions, is recalling one lot of its hydrocodone bitartrate and acetaminophen tablets because some may exceed the weight specification and could be super potent. A higher-than-intended dose of acetaminophen could result in liver toxicity, and a higher-than-intended dose of hydrocodone could cause an increase in the severity or frequency of side effects such as sedation, the company said. No injuries have been reported, it added.
Drug GMP Report
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.